What is Secure Transfusion Solutions?
Secure Transfusion Solutions is dedicated to revolutionizing the blood transfusion supply chain by providing institutions, regardless of size, with a consistent and reliable supplemental source of platelets. The company's innovative approach ensures that leading medical facilities can meet the transfusion needs of their patients with greater confidence. By partnering with STS, hospital systems bolster their operational resilience and preparedness, solidifying their commitment to patient care through advanced supply chain solutions.
How much funding has Secure Transfusion Solutions raised?
Secure Transfusion Solutions has raised a total of $15M across 1 funding round:
Debt
$15M
Debt (2022): $15M with participation from Horizon Technology Finance
Key Investors in Secure Transfusion Solutions
Horizon Technology Finance
Horizon Technology Finance is an investor in this funding round. Their specific investment focus within the healthcare or technology sectors is not detailed.
What's next for Secure Transfusion Solutions?
The recent major strategic investment signals a period of accelerated growth and market expansion for Secure Transfusion Solutions. This capital infusion is expected to fuel advancements in the company's technology and operational capacity, enabling STS to serve a broader range of healthcare providers. The company's focus on critical blood components positions it to address ongoing challenges in blood supply, making it a key player in the healthcare technology sector. Future developments will likely involve scaling production and forging deeper partnerships within the medical community to further its mission of ensuring blood component availability.
See full Secure Transfusion Solutions company page
